CDC Vaccine Panel Scraps Guidance for Universal Hepatitis B Shots at Birth

Scientific AmericanFriday, December 5, 2025 at 3:40:00 PM
NegativeScience
  • The CDC’s vaccine advisory panel has decided to eliminate the long-standing recommendation for universal hepatitis B vaccinations at birth, a measure credited with reducing infections by 99% in the United States. This decision marks a significant shift in public health policy regarding hepatitis B prevention.
  • The removal of this guidance raises concerns among health professionals and advocates who fear it may lead to an increase in hepatitis B infections, particularly among newborns who are at high risk. The panel's decision reflects ongoing debates about vaccination strategies and public health priorities.
  • This development highlights the complexities surrounding vaccine recommendations, as confusion within the CDC’s Advisory Committee on Immunization Practices during the voting process indicates potential discord among experts. Additionally, discussions about vaccine safety, including the role of adjuvants, continue to provoke scrutiny and debate, underscoring the challenges faced by health authorities in maintaining public trust.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
CDC panel, stuffed with vaccine skeptics, votes to end recommendation for universal newborn hepatitis B vaccination
NegativeScience
The CDC's vaccine advisory panel has voted to eliminate the universal recommendation for hepatitis B vaccinations at birth, a measure credited with a 99% reduction in infections in the United States. This decision reflects a significant shift in public health policy, particularly as the panel included members skeptical of vaccines.
Aluminum is Crucial to Vaccines—and Safe. Why are CDC advisers Debating It?
NeutralScience
RFK Jr.'s vaccine advisory panel is set to discuss the role of aluminum adjuvants in childhood vaccinations, a topic that has sparked significant debate regarding vaccine safety and efficacy. The panel's deliberations come amid ongoing scrutiny of vaccine components and their implications for public health.
CDC Vaccine Panel in Disarray over Hepatitis B Vote
NegativeScience
Members of the CDC’s Advisory Committee on Immunization Practices expressed confusion regarding a proposed recommendation for the birth dose of the hepatitis B vaccine, leading to disarray during the voting process.